[1]周冬娟.布地奈德联合西替利嗪治疗小儿哮喘对患儿呼吸功能及免疫功能指标的影响[J].医学信息,2022,35(03):103-105.[doi:10.3969/j.issn.1006-1959.2022.03.024]
　ZHOU Dong-juan.Effects of Budesonide Combined with Cetirizine on Respiratory Function andImmune Function in Children with Asthma[J].Medical Information,2022,35(03):103-105.[doi:10.3969/j.issn.1006-1959.2022.03.024]
点击复制

布地奈德联合西替利嗪治疗小儿哮喘对患儿呼吸功能及免疫功能指标的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年03期
页码:
103-105
栏目:
论著
出版日期:
2022-02-01

文章信息/Info

Title:
Effects of Budesonide Combined with Cetirizine on Respiratory Function andImmune Function in Children with Asthma
文章编号:
1006-1959（2022）03-0103-03
作者:
周冬娟
张家港市第一人民医院儿科，江苏 张家港 215600
Author(s):
ZHOU Dong-juan
Department of Pediatrics,Zhangjiagang First People’s Hospital,Zhangjiagang 215600,Jiangsu,China
关键词:
布地奈德; 西替利嗪; 小儿哮喘; 呼吸功能; 免疫功能
Keywords:
Budesonide; Cetirizine; Pediatric asthma; Respiratory function; Immune function
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2022.03.024
文献标志码:
A
摘要:
目的 分析布地奈德联合西替利嗪治疗小儿哮喘对呼吸功能及免疫功能指标的影响。方法 选择2018年1月-2021年5月张家港市第一人民医院儿科收治的小儿哮喘患者120例，采用随机数字表法分为对照组和观察组，各60例。对照组给予布地奈德治疗，观察组在对照组基础上加用西替利嗪治疗，比较两组临床疗效、治疗前后肺功能指标、免疫功能指标及不良反应发生率。结果 观察组总有效率高于对照组，差异有统计学意义（P＜0.05）；两组FVC、FEV1、MMF及MVV均高于治疗前，且观察组高于对照组，差异有统计学意义（P＜0.05）；观察组IgA低于对照组，IgG、IgM及IgE高于对照组，差异有统计学意义（P＜0.05）；两组嗜睡、腹痛腹泻、心率减缓、口干及头晕的发生率比较，差异无统计学意义（P＞0.05）。结论 布地奈德联合西替利嗪治疗小儿哮喘有助于缓解临床症状及体征，改善肺功能及免疫指标，且治疗期间无明显不良反应，安全性较好。
Abstract:
Objective To analyze the effect of budesonide combined with cetirizine on respiratory function and immune function in children with asthma.Methods A total of 120 children with asthma admitted to the Department of Pediatrics of Zhangjiagang First People’s Hospital from January 2018 to May 2021 were selected and randomly divided into control group and observation group, with 60 cases in each group. The control group was treated with budesonide, and the observation group was treated with cetirizine on the basis of the control group. The clinical efficacy, pulmonary function indexes before and after treatment, immune function indexes and incidence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group, and the difference was statistically significant (P<0.05). FVC, FEV1, MMF and MVV in the two groups were higher than those before treatment, and those in the observation group were higher than the control group, the difference was statistically significant (P<0.05). IgA in the observation group was lower than that in the control group, IgG, IgM and IgE were higher than those in the control group, the difference was statistically significant (P<0.05). There was no significant difference in the incidence of lethargy, abdominal pain and diarrhea, heart rate slowing, dry mouth and dizziness between the two groups (P>0.05).Conclusion Budesonide combined with cetirizine in the treatment of asthma in children is helpful to alleviate clinical symptoms and signs, improve lung function and immune indexes, and there is no obvious adverse reaction during treatment, with good safety.

参考文献/References:

[1]蔡戈利.两种剂量布地奈德治疗小儿哮喘急性发作临床观察[J].锦州医科大学学报,2018,39(5):49-51.[2]朱乔波,吴春红,肖佳荔,等.加用异丙托溴铵对哮喘患儿肺功能、炎症因子及VEGF表达的影响[J].实用药物与临床,2019,22(6):625-628.[3]中华医学会呼吸病学会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J].中华结核和呼吸杂志,2008,31(3):177-185.[4]吴嘉婴,洪建国.儿童支气管哮喘诊断和防治指南(2016年版)更新要点[J].世界临床药物,2018,39(8):512-517.[5]王敏,徐爱晶.布地奈德联合西替利嗪治疗小儿哮喘对血清解整合素-金属蛋白酶33及1-磷酸鞘氨醇水平的影响[J].儿科药学杂志,2020,26(2):18-21.[6]卢蓉,马科,李元霞,等.小青龙汤对小儿哮喘激素干预的增效作用及免疫调节观察[J].湖南中医药大学学报,2017,37(3):321-325.[7]董淑红,刘艳薇,魏锋,等.布地奈德联合不同药物雾化吸入疗法在儿童哮喘急性发作期的疗效评价[J].中国妇幼保健,2019,34(3):571-574.[8]申芳芳,张利利,杨秀梅,等.不同剂量布地奈德长期雾化吸入对儿童哮喘的临床效果观察[J].儿科药学杂志,2019,25(3):33-34.[9]Chen L,Qiong WU.Expression and clinical significance of serum interleukin-17,interleukin-33 and sphingosine 1-phosphate in patients with bronchial asthma[J].Journal of Cardiovascular ＆ Pulmonary Diseases,2018,37(2):107-111.[10]王永芳,王爱平,王璇,等.布地奈德联合复方异丙托溴铵雾化吸入治疗毛细支气管炎的疗效[J].儿科药学杂志,2018,24(2):30-32.[11]吴丙美,杨雪冰,寇永妹,等.西替利嗪滴剂联合布地奈德混悬液对小儿哮喘急性发作FENO和SOD的影响[J].中国医药导报,2019,16(14):144-147.[12]姜舒亚,杨霞,陈小桥,等.布地奈德雾化吸入对哮喘患儿血液调节性T细胞的影响[J].西北药学杂志,2019,34(1):98-101.[13]陈伟林,张允健,林小燕.雾化吸入布地奈德对哮喘患者下丘脑-垂体-肾上腺轴功能的影响[J].海南医学,2018,29(10):1439-1440.[14]卢素琴,洪燕.西替利嗪口服溶液联合布地奈德混悬液治疗小儿急性哮喘的临床研究[J].中国临床药理学杂志,2017,33(11):970-973.[15]孙妍.西替利嗪口服联合布地奈德吸入对小儿哮喘急性发作过程中免疫炎症反应的影响[J].海南医学院学报,2017,23(23):3271-3274.

相似文献/References:

[1]马建娟.布地奈德联合异丙托溴铵雾化治疗COPD 急性加重期的效果评价[J].医学信息,2018,31(07):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
　MA Jian-juan.Efficacy Evaluation of Budesonide Combined with Ipratropium Bromide in Treatment of Acute Exacerbation of COPD[J].Medical Information,2018,31(03):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
[2]罗玉霞.舒适护理在布地奈德联合氨溴索雾化吸入治疗 慢阻肺急性发作患者的效果分析[J].医学信息,2018,31(12):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
　LUO Yu-xia.Analysis of the Effect of Comfortable Nursing in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients with Aerosolized Inhalation of Budesonide and Ambroxol[J].Medical Information,2018,31(03):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
[3]张明荣.孟鲁司特钠联合布地奈德治疗小儿哮喘的临床疗效分析[J].医学信息,2018,31(13):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
　ZHANG Ming-rong.Clinical Analysis of Montelukast Sodium Combined with Budesonide in the Treatment of Childhood Asthma[J].Medical Information,2018,31(03):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
[4]邱亚双.辛夷鼻炎丸联合布地奈德治疗变应性鼻炎的临床观察[J].医学信息,2019,32(03):158.[doi:10.3969/j.issn.1006-1959.2019.03.052]
　QIU Ya-shuang.Clinical Observation of Xinyi Biyan Wan Combined with Budesonide in Treating Allergic Rhinitis[J].Medical Information,2019,32(03):158.[doi:10.3969/j.issn.1006-1959.2019.03.052]
[5]王 瑜.布地奈德混悬液联合特布他林治疗小儿哮喘的效果[J].医学信息,2022,35(12):184.[doi:10.3969/j.issn.1006-1959.2022.12.047]
　WANG Yu.Effect of Budesonide Suspension Combined with Terbutaline in the Treatment of Pediatric Asthma[J].Medical Information,2022,35(03):184.[doi:10.3969/j.issn.1006-1959.2022.12.047]
[6]王 雪,章 晔,李宝华.孟鲁斯特钠片与异丙托溴铵和布地奈德混悬液雾化吸入对小儿呼吸道感染性咳嗽的临床疗效[J].医学信息,2022,35(12):190.[doi:10.3969/j.issn.1006-1959.2022.12.049]
　WANG Xue,ZHANG Ye,LI Bao-hua.Clinical Effect of Montelukast Sodium Tablets Combined with Ipratropine Bromide and Budesonide Mixed Suspension Atomization Inhalation on Children with Respiratory Tract Infection Cough[J].Medical Information,2022,35(03):190.[doi:10.3969/j.issn.1006-1959.2022.12.049]
[7]周 佳,柴明思.布地奈德、异丙托溴铵气雾剂联合雾化吸入治疗对肺气肿患者肺功能及血液相关指标的影响[J].医学信息,2019,32(09):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
　ZHOU Jia,CHAI Ming-si.Effects of Budesonide and Ipratropium Bromide Aerosol Combined with Nebulized Inhalation on Pulmonary Function and Blood Related Indexes in Patients with Emphysema[J].Medical Information,2019,32(03):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
[8]韦春峥,莫 彬,莫善圆,等.孟鲁司特钠联合布地奈德治疗儿童支气管哮喘合并变应性鼻炎的临床效果[J].医学信息,2019,32(20):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
　WEI Chun-zheng,MO Bin,MO Shan-yuan,et al.Clinical Effect of Montelukast Sodium Combined with Budesonide in the Treatment of Children with Bronchial Asthma Complicated with Allergic Rhinitis[J].Medical Information,2019,32(03):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
[9]刘江海.异丙托溴铵雾化吸入治疗慢阻肺急性加重期的临床疗效[J].医学信息,2019,32(20):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
　LIU Jiang-hai.Clinical Efficacy of Ipratropium Bromide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,32(03):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
[10]甘 瀛.孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘的疗效[J].医学信息,2019,32(12):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]
　GAN Ying.Efficacy of Montelukast Sodium Combined with Budesonide in the Treatment of Cough Variant Asthma in Children[J].Medical Information,2019,32(03):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]

更新日期/Last Update: 1900-01-01